Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements

References

• Abo-Khatwa AN, al-Robai AA, al-Jawhari DA. Lichen acids as uncouplers of oxidative phosphorylation of mouse-liver mitochondria. Natural Toxins 1996; 4(2)96–102
   PubMedGoogle Scholar
• Arneborn P, Jansson A, Bottiger Y. Acute hepatitis in a woman after intake of slimming pills bought via Internet. Lakartidningen 2005; 102(28–29)2071–2072
   PubMedGoogle Scholar
• Blume H, Donath F, Warnke A, Schug BS. Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Safety 2006; 29(9)769–784
   PubMedGoogle Scholar
• Broksa B, Sturdikova M, Pronayova N, Liptaj T. (–)-Usnic acid and its derivatives. Their inhibition of fungal growth and enzyme activity. Pharmazie 1996; 51(3)195–196
   PubMed Web of Science ®Google Scholar
• Campanella L, Delfini M, Ercole P, Iacoangeli A, Risuleo G. Molecular characterization and action of usnic acid: A drug that inhibits proliferation of mouse polyomavirus in vitro and whose main target is RNA transcription. Biochimie 2002; 84(4)329–334
   PubMed Web of Science ®Google Scholar
• Cardarelli M, Serino G, Campanella L, Ercole P, De Cicco Nardone F, Alesiani O, Rossiello F. Antimitotic effects of usnic acid on different biological systems. Cell and Molecular Life Sciences 1997; 53(8)667–672
   PubMed Web of Science ®Google Scholar
• Cocchietto M, Skert N, Nimis PL, Sava G. A review on usnic acid, an interesting natural compound. Naturwissenschaften 2002; 89(4)137–146
   PubMedGoogle Scholar
• Colman E. Dinitrophenol and obesity: An early twentieth-century regulatory dilemma. Regulatory Toxicology and Pharmacology 2007; 48(2)115–117
   PubMed Web of Science ®Google Scholar
• Cornwell P, Slatter JG, De Souza AT, Rockett JC, Caguyong MJ, He YD, Dai X, Cheng O, Ulrich RG. Investigation of the hepatotoxicity of usnic acid using a compendium of rat liver gene expression profiles. Paper presented at the Society of Toxicology 45th Annual Meeting. San Diego, CAUSA March 2006, 2006; 5–9
   Google Scholar
• Correche ER, Enriz RD, Piovano M, Garbarino J, Gomez-Lechon MJ. Cytotoxic and apoptotic effects on hepatocytes of secondary metabolites obtained from lichens. Alternatives to Laboratory Animals 2004; 32(6)605–615
   PubMedGoogle Scholar
• Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H, Goldstein RL, Ghobrial M, Busuttil RW. Fulminant liver failure due to usnic acid for weight loss. American Journal of Gastroenterology 2004; 99(5)950–952
   PubMedGoogle Scholar
• Elo H, Matikainen J, Pelttari E. Potent activity of the lichen antibiotic (+)-usnic acid against clinical isolates of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Naturwissenschaften 2007; 94(6)465–468
   PubMedGoogle Scholar
• Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Archives of Surgery 2003; 138: 852–858
   PubMed Web of Science ®Google Scholar
• Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Coody GL, Love LA, Fong T. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Annals of Internal Medicine 2002; 136(8)290–595
   Google Scholar
• Frankos VH. Nomination for usnic acid and Usnea barbata herb. National Toxicology Program, Washington, DC 2005, Food and Drug Administration, Division of Dietary Supplement Programs (available at: http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/UsnicAcid.pdf)
   Google Scholar
• Gibson JE, Taylor DA. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?. Journal of Pharmacology and Experimental Therapeutics 2005; 314(3)939–944
   PubMedGoogle Scholar
• Ha-Duong NT, Dijols S, Marques-Soares C, Minoletti C, Dansette PM, Mansuy D. Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily. Journal of Medicinal Chemistry 2001; 25(44)3622–3631
   Google Scholar
• Han D, Matsumaru K, Rettori D, Kaplowitz N. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochemical Pharmacology 2004; 67(3)439–451
   PubMed Web of Science ®Google Scholar
• Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, McLeod HL. UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. Journal of the National Cancer Institute 2007; 99(17)1290–1295
   PubMedGoogle Scholar
• Hsu LM, Huang YS, Chang FY, Lee SD. ‘Fat burner’ herb, usnic acid, induced acute hepatitis in a family. Journal of Gastroenterology and Hepatology 2005; 20(7)1138–1139
   PubMed Web of Science ®Google Scholar
• Indiana University School of Medicine. Drug Interactions Table. Indianapolis 2007, IN: Indiana University School of Medicine (available at: http://medicine.iupui.edu/flockhart/table.htm)
   Google Scholar
• Koparal AT, Tuylu BA, Turk H. In vitro cytotoxic activities of (+)-usnic acid and (–)-usnic acid on V79, A549, and human lymphocyte cells and their non-genotoxicity on human lymphocytes. Natural Product Research 2006; 20(14)1300–1307
   PubMed Web of Science ®Google Scholar
• Krishna DR, Ramana DV, Mamidi NV. In vitro protein binding and tissue distribution of D(+) usnic acid. Drug–Metabolite–Drug Interactions 1995; 12(1)53–63
   PubMedGoogle Scholar
• Krishna DR, Venkataramana D. Pharmacokinetics of D(+)-usnic acid in rabbits after intravenous and oral administration. Drug Metabolism and Disposition 1992; 20(6)909–911
   PubMedGoogle Scholar
• Kristmundsdottir T, Aradottir HA, Ingolfsdottir K, Ogmundsdottir HM. Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. Journal of Pharmacy and Pharmacology 2002; 4(11)1447–1452
   Google Scholar
• Kumar KC, Muller K. Lichen metabolites 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism. Journal of Natural Products 1999a; 62(6)817–820
   PubMedGoogle Scholar
• Kumar KC, Muller K. Lichen metabolites 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic and diffractaic acid on human keratinocyte growth. Journal of Natural Products 1999; 62(6)821–823
   PubMed Web of Science ®Google Scholar
• Kuo IF, Chen J, Chang TKH. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: Role of ginkgolides, bilobalide, and flavonols. Canadian Journal of Physiology and Pharmacology 2004; 82(1)57–64
   PubMedGoogle Scholar
• Kutney JP, Baarschers WH, Chin O, Ebizuka Y, Hurley L, Leman JD, Salisbury PJ, Sanchez IH, Yee T, Bandoni RJ. Studies on the usnic-acid series: Part 8: The biodegradation of dextro usnic-acid by Mortierella isabellina. Canadian Journal of Chemistry 1977; 55: 2930–2940
   Google Scholar
• Mayer M, O’Neill MA, Murray KE, Santos-Magalhaes NS, Carneiro-Leao AM, Thompson AM, Appleyard VC. Usnic acid: A non-genotoxic compound with anti-cancer properties. Anticancer Drugs 2005; 16(8)805–809
   PubMed Web of Science ®Google Scholar
• Miners JO, Knights KM, Houston JB, Mackenzie PI. In vitro–in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises. Biochemical Pharmacology 2006; 71(11)1531–1539
   PubMed Web of Science ®Google Scholar
• Nath A, Atkins WM. A theoretical validation of the substrate depletion approach to determining kinetic parameters. Drug Metabolism and Disposition 2006; 34: 1433–1435
   PubMed Web of Science ®Google Scholar
• Neff GW, Reddy KR, Durazo FA, Meyer D, Marrero R, Kaplowitz N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. Journal of Hepatology 2004; 41(6)1062–1064
   PubMedGoogle Scholar
• Obach RS, Reed-Hagen AE. Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. Drug Metabolism and Disposition 2002; 30: 831–837
   PubMed Web of Science ®Google Scholar
• Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M, Kazaz C. Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. Journal of Ethnopharmacology 2006; 103(1)59–65
   PubMed Web of Science ®Google Scholar
• Polson J, Lee WM. American Association for the Study of Liver Disease (AASLD) Position Paper: The management of acute liver failure. Hepatology 2005; 41(5)1179–1197
   PubMed Web of Science ®Google Scholar
• Pramyothin P, Janthasoot W, Pongnimitprasert N, Phrukudom S, Ruangrungsi N. Hepatotoxic effect of (+)usnic acid from Usnea siamensis Wainio in rats, isolated rat hepatocytes and isolated rat liver mitochondria. Journal of Ethnopharmacology 2004; 90(2–3)381–387
   PubMedGoogle Scholar
• Rafanelli S, Bacchilega R, Stanganelli I, Rafanelli A. Contact dermatitis from usnic acid in vaginal ovules. Contact Dermatitis 1995; 33(4)271–272
   PubMed Web of Science ®Google Scholar
• Rancan F, Rosan S, Boehm K, Fernandez E, Hidalgo ME, Quihot W, Rubio C, Boehm F, Piazena H, Oltmanns U. Protection against UVB irradiation by natural filters extracted from lichens. Journal of Photochemistry and Photobiology B 2002; 68(2–3)133–139
   PubMedGoogle Scholar
• Registry of Toxic Effects of Chemical Substances (RTECS). 2007, RTECS Database 2007 (available at: http://csi.micromedex.com/)
   Google Scholar
• Rettie AE, Jones JP. Clinical and toxicological relevance of CYP2C9: drug–drug interactions and pharmacogenetics. Annual Reviews in Pharmacology and Toxicology 2005; 45: 477–494
   PubMed Web of Science ®Google Scholar
• Sanchez W, Maple JT, Burgart LJ, Kamath PS. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clinic Proceedings 2006; 81(4)541–544
   PubMedGoogle Scholar
• Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Reichen J, Zimmer. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. Journal of Hepatology 2007; 47(4)521–526
   PubMed Web of Science ®Google Scholar
• Sheu M, Simpson EL, Law SV, Storrs FJ. Allergic contact dermatitis from a natural deodorant: A report of 4 cases associated with lichen acid mix allergy. Journal of the American Academy of Dermatology 2006; 55(2)332–337
   PubMedGoogle Scholar
• Takai M, Uehara Y, Beisler JA. Usnic acid derivatives as potential antineoplastic agents. Journal of Medicinal Chemistry 1979; 22(11)1380–1384
   PubMed Web of Science ®Google Scholar
• Temple R. Hy's law: Predicting serious hepatotoxicity. Pharmacoepidemiology and Drug Safety 2006; 15(4)241–243
   PubMed Web of Science ®Google Scholar
• Ulbricht C, Basch E, Weissner W, Hackman D. An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opinion on Drug Safety 2006; 5(5)719–728
   PubMed Web of Science ®Google Scholar
• Ulrich RG. Idiosyncratic toxicity: A convergence of risk factors. Annual Reviews in Medicine 2007; 58: 17–34
   PubMed Web of Science ®Google Scholar
• Food US. Frug Administration. FDA warns consumers not to use the dietary supplement LipoKinetix. College Park, , MD 2001, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements, US Food and Drug Administration. 19 November 2001 (available at: http://www.cfsan.fda.gov/∼dms/dslipo.html)
   Google Scholar
• Venkataramana D, Krishna DR. High-performance liquid chromatographic determination of usnic acid in plasma. Journal of Chromatography 1992; 575(1)167–170
   PubMedGoogle Scholar
• Venkataramana D, Krishna DR. Pharmacokinetics of d(+)-usnic acid in rabbits after intravenous administration. European Journal of Drug Metabolism and Pharmacokinetics 1993; 18(2)161–163
   PubMedGoogle Scholar